# PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"

> **NCT05829499** · NA · COMPLETED · sponsor: **C.O.C. Farmaceutici S.r.l.** · enrollment: 20 (actual)

## Conditions studied

- Allergic Conjunctivitis
- Dry Eye
- Dry Eye Disease

## Interventions

- **DEVICE:** HPMC-HA eyedrops

## Key facts

- **NCT ID:** NCT05829499
- **Lead sponsor:** C.O.C. Farmaceutici S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-02
- **Primary completion:** 2023-02-06
- **Final completion:** 2023-02-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05829499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05829499, "PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05829499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*